Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Canaccord Genuity Wealth Limited - Form 8.3 - [ALLIANCE PHARMA PLC - 18 02 2025] - (CGWL)
Form 8.3 - [ALLIANCE PHARMA PLC - 18 02 2025] - (CGWL)
GlobeNewswire

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED…

bloomberg.com - Damian Garde - Pharma Leaders to Meet Trump in Push to Tweak Drug Policies
Pharma Leaders to Meet Trump in Push to Tweak Drug Policies
Bloomberg

The industry aims to convince Trump to scale back pricing law Drugmaker CEOs, PhRMA head Stephen Ubl to attend meeting The pharmaceutical industry's biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according to…

investopedia.com - Nisha Gopalan - Trump Suggests 25% Tariffs on Auto, Chip, Pharma Imports, Reports Say
Trump Suggests 25% Tariffs on Auto, Chip, Pharma Imports, Reports Say
Investopedia

President Trump is considering tariffs of 25% or more on automobiles, semiconductors and pharmaceutical products imports into the U.S., according to reports. According to The Wall Street Journal, Trump told reporters Tuesday that tariffs would be…

pitcher.com - Dorota - You Spoke, We Listened: Top Challenges in Pharma for 2025 - Pitcher
You Spoke, We Listened: Top Challenges in Pharma for 2025 - Pitcher
Home - Pitcher

At the recent NEXT Pharma CX and AI Conference in Vienna, the Pitcher team connected with hundreds of Pharma professionals to discuss the future of the industry. As a sponsor, we engaged with Pharma executives and engagement team leads who shared…

thedailystar.net - Star Business Report - Square Pharma's sponsor to buy Tk 32cr shares in it
Square Pharma's sponsor to buy Tk 32cr shares in it
The Daily Star

Square Pharmaceuticals' Director Anjan Chowdhury yesterday expressed his intention to buy 15 lakh shares of his company, the largest drug producer in Bangladesh. The value of the shares was Tk 32 crore as per the closing price of Square…

business-standard.com - Nikita Vashisht - Suven Pharma, Divis, Syngene: Why Macquarie is betting big on Indian pharma
Suven Pharma, Divis, Syngene: Why Macquarie is betting big on Indian pharma
Business Standard

The Indian pharmaceutical industry, especially the CRDMO segment, could be at an inflection point, believe analysts at Macquarie. Increased pharmaceutical outsourcing, coupled with regulatory tailwinds, the brokerage said, could accelerate the…

afr.com - Hadriana Lowenkron, Josh Wingrove - Trump floats 25pc tariffs on cars, pharma and semiconductor chips
Trump floats 25pc tariffs on cars, pharma and semiconductor chips
Australian Financial Review

Hadriana Lowenkron and Josh Wingrove Gift 5 articles to anyone you choose each month when you subscribe. Subscribe now Already a subscriber? Washington | President Donald Trump said he was likely to impose tariffs on cars, semiconductor chips and…

pitcher.com - Dorota - Pharma Thought Leaders Discuss Best Practices for AI Transformation - Pitcher
Pharma Thought Leaders Discuss Best Practices for AI Transformation - Pitcher
Home - Pitcher

The NEXT CX & AI Conference in Vienna brought together hundreds of industry leaders from over 25 countries to discuss the future of AI in Pharma. Pitcher's very own omnichannel expert Dirk Abeel, who leads Global GTM and Customer Success, joined…

business-standard.com - Capital Market - Orchid Pharma's Alathur facility completes USFDA inspection
Orchid Pharma's Alathur facility completes USFDA inspection
Business Standard

Orchid Pharma announced the successful completion of a surprise U.S. Food and Drug Administration (USFDA) inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility in Alathur, Tamil Nadu. The inspection, which commenced on 10…

newswire.ca - Innocan Pharma Corporation - Innocan Pharma Granted First Patent in India for its Liposomal CBD Injection
Innocan Pharma Granted First Patent in India for its Liposomal CBD Injection
CNW

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ('Innocan' or the…

business-standard.com - Reuters - Indian drugmakers face risks as Trump eyes tariffs on US imports of pharma
Indian drugmakers face risks as Trump eyes tariffs on US imports of pharma
Business Standard

US President Donald Trump said on Tuesday he intends to impose a '25 per cent or higher' levies on semiconductors and pharmaceutical imports, and raise it substantially over the course of a year, a move likely to hit India's sprawling…

scotsman.com - Scott Reid - Scottish pharma firm Kelso seals 'milestone' deal on European growth journey
Scottish pharma firm Kelso seals 'milestone' deal on European growth journey
The Scotsman

“Our aim has always been to build a specialty pharma business that puts patients first” – Tom Stratford, CEO Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our…

business-standard.com - Rex Cano - How to trade Nifty Auto, IT, Pharma as Trump threatens up to 25% tariffs
How to trade Nifty Auto, IT, Pharma as Trump threatens up to 25% tariffs
Business Standard

The Nifty Auto, IT and Pharma indices started Wednesday's trading session with losses over 2 per cent after the US President Donald Trump threatened up to 25 per cent tariffs on automobile, semiconductor and pharmaceutical imports. The Nifty…

business-standard.com - Capital Market - Aurobindo Pharma Ltd Falls 6.07%, BSE Healthcare index Drops 2.12%
Aurobindo Pharma Ltd Falls 6.07%, BSE Healthcare index Drops 2.12%
Business Standard

Home / Markets / Capital Market News / Aurobindo Pharma Ltd Falls 6.07%, BSE Healthcare index Drops 2.12% Last Updated: Feb 19 2025 | 9:50 AM IST Aurobindo Pharma Ltd has lost 9.09% over last one month compared to 8.4% fall in BSE Healthcare index…

business-standard.com - Capital Market - Stock Alert: L&T, Piramal Pharma, Puravankara, Mahindra Lifespace Developers
Stock Alert: L&T, Piramal Pharma, Puravankara, Mahindra Lifespace Developers
Business Standard

Home / Markets / Capital Market News / Stock Alert: L&T, Piramal Pharma, Puravankara, Mahindra Lifespace Developers Last Updated: Feb 19 2025 | 9:06 AM IST Securities in F&O Ban: Deepak Nitrite, Manappuram Finance shares are banned from F&O trading…

Receive a Daily briefing on Pharma Industry News

Get Started